4 Results for "

IRAK4-IN-6

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "IRAK4-IN-6" in MCE Product Catalog:

Cat. No.: HY-130253
CAS No.: 2454244-02-9
Purity:  99.30%
Target:  

IRAK

Research Areas:  

Cancer

IRAK4-IN-6 is an orally efficacious and selective IRAK4 inhibitor with an IC50 of 4 nM, and targetes MyD88 L265P mutant diffuse large B cell lymphoma .
loading...
    loading...
Cat. No.: HY-139317
CAS No.: 2360530-72-7
Target:  

PROTACs IRAK

Research Areas:  

Cancer

PROTAC IRAK4 degrader-6 is a Cereblon-based PROTAC as interleukin-1 receptor-associated kinase 4 (IRAK4) degrader extracted from patent US20190192668A1, compound I-172 .
loading...
    loading...
Cat. No.: HY-139318
CAS No.: 2408878-25-9
Research Areas:  

Others

IRAK4 ligand-16 is a IRAK4 ligand and can be used for the synthesis of PROTACs, such as PROTAC IRAK4 degrader-4 (HY-139315) and PROTAC IRAK4 degrader-6 (HY-139317) .
loading...
    loading...
Cat. No.: HY-184672
CAS No.: 2357108-46-2
Research Areas:  

Cancer

Thalidomide-NH-C2-NH-C5-NH2 is an E3 ligase ligand-linker conjugate that can be used for PROTAC synthesis. Thalidomide-NH-C2-NH-C5-NH2 serves as the E3 ligase ligand-linker conjugate moiety of PROTAC IRAK4 degrader-6 (HY-139317) .
loading...
    loading...